A blistering assessment by the Department of Defense inspector general uncovered a slew of flaws with the White House Medical Unit under the previous Trump administration. The investigation detailed serious infractions, including the suspected distribution of restricted narcotics to ineligible White House employees in blatant violation of federal law and protocol.
According to the audit, restricted pharmaceuticals ranging from opioids to sleeping pills were improperly maintained, with handwritten notes utilized for inventory tracking, resulting in frequent errors.
Allegations against the Trump administration
A new study by the Department of Defense Inspector General discovered that the White House Medical Unit’s practices included prescribing drugs such as Ambien without adequate verification. It also claims that pricey brand-name drugs, such as Ambien and Provigil, were acquired, which it claims are 174 and 55 times “more expensive than the generic equivalent”. This demonstrates a tremendous lack of financial accountability.
The incorrect disposal of both regulated and non-controlled medications demonstrated a systemic failure in pharmaceutical management.
The report’s analysis emphasized that “White House medical officials did not consider their operations a pharmacy,” demonstrating a significant gap in perception and professional accountability.
Without the supervision of qualified pharmacy workers, the report warned of potential medication errors and highlighted concerns about the health and safety of patients treated on the unit.
“Without oversight from qualified pharmacy staff, the White House medical unit’s pharmaceutical management practices might have been subject to prescribing errors,” the statement said.
“Additionally, the White House medical unit’s practices demonstrated inadequate medication management and increased risk to the health and safety of patients treated within the unit.”
What sparked this investigation?
The inquiry was initiated by accusations from 2018, according to CBS News.
“In 2018, the DoD Office of Inspector General (DoD OIG) Hotline received complaints alleging that a senior military medical officer assigned to the White House Medical Unit engaged in improper medical practices,” says the report. However, the report did not explicitly name individuals.
US Representative Ronny Jackson, who commanded the White House Medical Unit during the investigation, has previously faced controversy over medicine delivery and unethical behavior.
Senator Jon Tester, also known as the “candy man,” accused him of loosely administering sleep-related drugs like Ambien and Provigil. In 2018, Tester told CNN that “in the White House, they call him the ‘candy man.'”
